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ABSTRACT
Objective To review the evidence on the diagnostic
accuracy of the currently available point of care D-dimer
tests for excluding venous thromboembolism.
Design Systematic review of research on the accuracy of
point of care D-dimer tests, using bivariate regression to
examine sources of variation and to estimate sensitivity
and specificity.
Data sources Studies on the diagnostic accuracy of point
of care D-dimer tests published between January 1995
and September 2008 and available in either Medline or
Embase.
Review methods The analysis included studies that
compared point of care D-dimer tests with predefined
reference criteria for venous thromboembolism, enrolled
consecutive outpatients, and allowed for construction of
a2 ×2 table.
Results 23 studies (total number of patients 13959,
range in mean age 38-65 years, range of venous
thromboembolism prevalence 4-51%) were included in
the meta-analysis. The studies reported two qualitative
point of care D-dimer tests (SimpliRED D-dimer (n=12)
and Clearview Simplify D-dimer (n=7)) and two
quantitative point of care D-dimer tests (Cardiac D-dimer
(n=4)andTriageD-dimer(n=2)).Overallsensitivityranged
from 0.85 (95% confidence interval 0.78 to 0.90) to 0.96
(0.91 to 0.98) and overall specificity from 0.48 (0.33 to
0.62) to 0.74 (0.69 to 0.78). The two quantitative tests
Cardiac D-dimer and Triage D-dimer scored most
favourably.
Conclusions In outpatients suspected of venous
thromboembolism, point of care D-dimer tests can
contribute important information and guide patient
management, notably in low risk patients (that is, those
patients with a low score on a clinical decision rule).
INTRODUCTION
Diagnosing patients suspected of venous thrombo-
embolism—that is, deep venous thrombosis (DVT) or
pulmonaryembolism(PE)—isamajorchallengebecause
thesignsandsymptomsareoftenmildandnon-specific.
12
Primarycarephysiciansinparticular,whoinmanycoun-
tries are faced with the initial presentation of venous
thromboembolism and have to decide whether to refer
patients for subsequent testing or not, can have difficulty
diagnosing venous thromboembolism.
D-dimer testing can be used to improve the cost
effectiveness of the diagnostic process. D-dimers are
degradation products of cross linked fibrin that are
generated during fibrinolysis, and circulating levels are
typically elevated in patients with venous thrombo-
embolism. A negative result in a D-dimer test in combi-
nation with a low pre-test probability of venous
thromboembolism (as assessed by a validated clinical
decision rule) can safely rule out DVT as well as PE.
3-6
A large variety of laboratory D-dimer testsare currently
available and their accuracy has been described
extensively.
78
Recently, various point of care or “near patient”
D-dimer tests have been introduced. These D-dimer
tests can be performed during the consultation of a
patient and results are already available within
10-15 minutes. Using these tests could avoid the need
for more labour intensive and time consuming labora-
tory D-dimer testing. This advantage is especially use-
ful for primary care physicians, as they often have to
decide on further patient management during the con-
sultation of a patient with suspected venous throm-
boembolism. In this setting, referral for conventional
laboratory D-dimer testing could be either impractical
owing to limited access to central laboratories or time
consuming for both patient and doctor. Furthermore,
venousthromboembolismisconfirmedbysubsequent
imaging tests in only 10-20% of all referred patients.
6
ApplicationofpointofcareD-dimertestscould,there-
fore, be cost effective not only in primary care patients
suspectedofvenousthromboembolismbutalsoinsec-
ondary care outpatients, notably those presenting at
emergency departments. Another advantage in this
settingisthatatestresultcanbeobtainedmorerapidly
than when using conventional laboratory testing.
Two systematic reviews concluded that a low clinical
probability (as assessed by the clinical decision rule
developed by Wells et al
6)a n dan e g a t i v er e s u l to n
SimpliRED D-dimer (a point of care assay; Agen
Biomedical, Brisbane, Australia) could safely exclude
venous thromboembolism.
910 There has nevertheless
been much discussion about the diagnostic accuracy
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D-dimer test, mainly because of the low interobserver
agreement associated with this assay.
1112 P e r h a p sa sa
consequence, several new point of care D-dimer tests
have been introduced in recent years. Such tests have
neverbeensubjecttoaformal(diagnostic)meta-analysis
because studies on their diagnostic performance were
not available at the time of the two latest systematic
reviews.
910 Before these new point of care tests are
widely implemented in daily practice, however, their
diagnostic performance has to be thoroughly evaluated.
We conducted a diagnostic meta-analysis to assess
the accuracy of all currently available point of care
D-dimer tests, with particular focus on their ability to
exclude either DVT or PE in suspected outpatients.
METHODS
Data sources and searches
We performed a systematic search of two online data-
bases to identify studies evaluating the diagnostic
accuracy of point of care D-dimer tests for the exclu-
sion of DVT and PE. Sources were articles in Medline
andEmbasepublishedbetween1995and1September
2008. The search strategy included (“fibrin fibrinogen
degradationproducts”OR“D-dimer”)combinedwith
(“venous thrombosis” OR “pulmonary embolism”.
We restricted our search to studies published in Eng-
lish only. Duplicate articles identified in both Medline
and Embase were manually deleted using Reference
Manager,version11(ThomsonReuters,Philadelphia,
PA,USA).Thereferencelistsofidentifiedstudieswere
checked forfurther relevant studies,and experts in the
field recommended further articles to complement the
electronic searches.
Point of care D-dimer tests under study
D-dimers are degradation products of cross linked
fibrin generated during fibrinolysis. D-dimer, how-
ever, is not a single entity in plasma but a mixture of
heterogeneous fibrin degradation products. Different
assays measure different types of D-dimer; conse-
quently, test results are reported as μg/ml D-dimer
units (D-DU), μg/ml fibrinogen equivalent units
(FEU), or ng/ml. No single cut off value for all assays
exists, and attempts to standardise D-dimer testing
havefailed.
13Hence,anyD-dimertestcanonlybecor-
rectlyvalidatedagainstareferencestandardforvenous
thromboembolism(forexample,compressionultraso-
nography for DVT). We included four different point
ofcareD-dimertestsinourmeta-analysis:twoqualita-
tive tests and two quantitative tests.
SimpliRED D-dimer
SimpliRED D-dimer is a semiqualitative test per-
formed by mixing capillary or venous blood with a
drop of test reagent in the test well. A positive result
is defined as any visible agglutination within two min-
utes. Visible agglutination will occur if D-dimer levels
exceed 200 μg/l.
Clearview Simplify D-dimer
Clearview Simplify D-dimer (Inverness Medical, Bed-
ford, UK)is a qualitativetest andis performedby mix-
ing35μlofcapillaryorvenousbloodwithtwodropsof
testreagent.ApositivetestresultoccurswhenD-dimer
levels exceed 80 ng/ml and is indicated by a visible
pink-purple coloured line that forms at the test zone.
Testresultsarevalidifapink-purplelineisalsopresent
at the control zone. The test can be read within
10 minutes.
Cardiac D-dimer
Cardiac D-dimer (Roche Diagnostics, Mannheim,
Germany) is performed with 150 μl whole venous
blood and a small portable instrument (Cobas h 232;
Roche Diagnostics). The instrument displays a quanti-
tative result within a range of 0.1-4.0 μg/ml FEU. A
threshold value of 0.5 μg/ml FEU is used, above
which a test result is called positive. Test results are
available within 10-15 minutes.
SimpliRED
D-dimer
(n=12)
Clearview
Simplify
D-dimer
(n=7)
Cardiac
D-dimer
(n=4)
Triage
D-dimer
(n=2)
Citations reviewed (n=2022):
  Medline citations (n=967) 
  Embase citations (n=1053)
  Personal communications (n=2)
Review or meta-analysis
Letter or case report
Not a diagnostic study*
Not on D-dimer†
Not on a POC D-dimer test
Not on VTE‡
Study in children
Embase
excluded
(n=897):
(n=286)
(n=246)
(n=207)
(n=49)
(n=58)
(n=45)
(n=6)
Medline
excluded
(n=766):
(n=249)
(n=151)
(n=198)
(n=78)
(n=63)
(n=21)
(n=6)
Studies retrieved for detailed review (n=203§)
Studies included in the analysis (n=23**)
Citations excluded (inclusion criteria not met) (n=180):
  Letter, case report, or review (n=15)
  Not a diagnostic study* (n=15)
  Not on a POC D-dimer test (n=130)
  Sensitivity and specificity could not be calculated¶ (n=8)
  Study included inpatients (n=6)
  Study described subgroup of another study (n=6)
Fig 1 | Flowchart of included studies. *Instead an aetiological
study; for example, a study on risk factors for venous
thromboembolism or number of ventilation-perfusion lung
scans ordered as a function of D-dimer testing. †Studies
investigating other biomarkers, such as P-selectin, or other
tests, such as electrocardiography. ‡Studies that did not use
venous thromboembolism as the outcome, but aortic
dissection or mesenterial thrombosis, for example. §156 of
203 studies were found in both Embase and Medline. ¶For
example, because D-dimer testing was only performed in
patients with a positive ultrasonogram. **One study
compared three different point of care D-dimer tests.
Abbreviations: POC, point of care; VTE, venous
thromboembolism
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Triage D-dimer (Biosite, San Diego, CA, USA) is per-
formedwith250 μlofwholebloodtreatedwithEDTA
and a small portable instrument (Triage Meter Plus;
Biosite). The Triage Meter Plus displays a quantitative
result within a range of 0.1-5 μg/ml D-DU, using a cut
offvalueof0.35μg/mlD-DU.Testresultsareavailable
within 10-15 minutes.
Study selection
To be eligible for inclusion, the studies had to fulfil the
following criteria:
1) Have a study population of consecutive
outpatients (age >18 years) in primary or secondary
care who were clinically suspected of DVT
(proximal or distal) and/or PE
2) Assess a point of care D-dimer test; that is, a test
that is performed in a near patient situation in the
emergency department or at the physician’s office
and not on a routine laboratory machine
3) Use compression ultrasonography, venography,
impedance plethysmography, or uneventful
follow-up (that is, no DVT or PE in at least three
months, an accepted reference standard in this field
of research
6) as a reference test for DVT
4) Use computerised tomography pulmonary
angiography, ventilation-perfusion lung scanning,
pulmonary angiography, or uneventful follow-up as
a reference test for PE
5) Include calculation of sensitivity, specificity,
negative and positive predictive values, and
prevalence of DVT or PE.
Data extraction
Tworeviewers(GJGandKJMJ)independentlyextracted
thefollowingcharacteristicsfromeachstudy:prevalence
ofDVTandPE;percentagemales;percentageofpatients
with an active malignancy; percentage of patients with
recent surgery (<4 weeks); and mean age of the patients.
If the study addressed DVT, the percentage of patients
with a distal (calf) vein thrombosis and the percentage of
patients with a previous DVT were also extracted.
Finally, the number of true positives, false positives,
true negatives, and false negatives for the index test
were extracted from the studies and a 2×2t a b l ew a sc o n -
structed. Discrepancies were resolved by discussion
between the two reviewers and if agreement could not
be reached, a third or fourth reviewer was consulted
(RO and KGMM). Authors of the respective studies
were contacted to provide further details in cases where
information was missing from the articles.
Quality assessment
The methodological quality of the selected studieswas
graded independently by two reviewers (GJG and
KJMJ) with the Quality Assessment of Diagnostic
Accuracy Studies (QUADAS) tool, a validated tool
for the quality assessment of diagnostic accuracy
studies.
14 In case of doubt, a third and fourth reviewer
(RO and KGMM) were consulted.
Data synthesis and analysis
Weusedthebivariatemodelfordiagnosticmeta-analysis
toobtainanoverallsensitivityandanoverallspecificity.
15
Instead of using the diagnostic odds ratio, as used in
conventional diagnostic meta-analytical methods,
16 the
bivariateapproachusespairsofsensitivityandspecificity
as the starting point of the analysis. Besides accounting
for study size, the bivariate model estimates and
incorporates the negative correlation that may arise
between the sensitivity and specificity of the index test
within studies as a result of differences in test positive/
negative threshold between studies. These threshold
differences are particularly important for the qualitative
pointofcare D-dimer tests, asthe thresholdunderlying a
positive result in such tests is unknown or implicit. The
bivariate model uses a random effects approach for both
sensitivityandspecificity,whichallowsforheterogeneity
beyond chance as a result of clinical and methodological
differences between studies. To examine sources of
heterogeneity, different study characteristics were
addedtothemodelascovariates.Forreasonsofstatistical
power, we performed such a meta-regression analysis
for only point of care D-dimer tests assessed in at least
10 studies. For the remaining tests, we simply performed
a subgroup analysis across relevant subgroups of the
covariate. Evidence for publication bias through small
study effects was explored with a regression test on the
diagnostic odds ratio.
17
Wedefinedapriorithefollowingclinicalanddesign
characteristics of a study as potential relevant covari-
ates: type of venous thromboembolism (DVT or PE);
proportionof patientswith a proximal DVT (for DVT
studies only); proportion of patients with a recurrent
DVT (for DVT studies only); proportion of patients
with an active malignancy; and proportion of patients
with recent surgery (<4 weeks). The QUADAS tool
criteria,inparticulardifferentialverificationandincor-
poration bias, were also examined as potential sources
of bias.
QUADAS tool criterion
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Representative patient sample
Selection criteria clearly described
Adequate reference standard
Cross sectional design
Complete verification of diagnosis
No differential verification
No incorporation bias
Adequate index test description
Adequate reference test description
Blinding for reference test results
Blinding for index test results
Clinical data available as in practice
Uninterpretable test results reported
Withdrawals explained 0
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Fig 2 | Proportion of all 14 Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool
criteria that were fulfilled
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individual and summary points of sensitivity and spe-
cificity in a receiver operating characteristic graph,
plotting the index test’s sensitivity (true positive rate)
on the y axis against 1-specificity (false negative rate)
on the x axis. In addition, we plotted the 95%
Table 1 |Population and study characteristics of included studies
Study
No of
partici-
pants
Mean age
(years)
Proportion
males (%)
Proportion
with active
malignancy
(%)
Proportion
with recent
surgery (%)
Prevalence
VTE (%)
Prevalence
distalDVT(%)
*
Prevalence
recurrent DVT
(%)*
Proportion of
patients who
underwent
imaging and
follow-up (%)†
Reference test
used
DVT studies
SimpliRED D-dimer
Wells et al, 1995
w13 214 56 37 ? ? 25 12 0 100/0 Venography
Anderson et al,
2000
w3
214 54 44 5 5 13 0 0 100/0 CUS and
venography
van der Graaf et al,
2000
w12
99 58 38 ? 0 51 12 ? 100/0 Venography
Kearon et al, 2001
w8 443 60 36 ? ? 14 ? 0 60/40 Combined‡
Bozic et al, 2002
w5 135 60 39 ? ? 38 19 ? 100/0 CUS
Kraaijenhagen et al,
2002
w11
1695 60 37 13 15 22 0 0 100/0 CUS
Anderson et al,
2003
w4
1057 57 43 5 10 18 0 ? 70/30 Combined‡
Kilroy et al, 2003
w9 279 ? ? ? ? 14 ? ? 100/0 CUS
Clearview Simplify D-dimer
Neale et al, 2004
w17 187 ? 46 ? ? 27 ? ? 100/0 Venography
Subramaniam et al,
2006
w19
453 55 35 ? ? 19 63 0 100/0 CUS
Toll et al, 2008
w2 200 59 33 2 2 12 0 16 100/0 CUS
AMUSE study,
2009
w1
1002 57 37 5 8 13 0 15 50/50 Combined‡
Cardiac D-dimer
Bucek et al, 2001
w22 85 58 41 31 ? 41 22 ? 100/0 CUS and
venography
Legnani et al,
2003
w20
80 21-94§ 40 ? ? 40 0 0 100/0 CUS
Dempfleetal,2006
w2
1
560 57 38 6 0 39 0 0 100/0 CUS
Toll et al, 2008
w2 200 59 33 2 2 12 0 16 100/0 CUS
Triage D-dimer
Toll et al, 2008
w2 200 59 33 2 2 12 0 16 100/0 CUS
PE studies
SimpliRED D-dimer
Ginsberg et al,
1998
w7
1177 53 41 ? ? 17 NA NA 100/0 Other¶
Kline et al, 2001
w10 380 50 30 15 12 17 NA NA 100/0 Other¶
Wells et al, 2001
w14 930 50 37 7 8 9 NA NA 50/50 Combined‡
Clearview Simplify D-dimer
Hogg et al, 2005
w15 417 38 48 1 1 5 NA NA 41/59 Combined‡
Kline et al, 2006
w16 2302 44 31 8 5 4 NA NA 45/55 Combined‡
Runyonetal,2008
w18 1169 47 34 5 5 4 NA NA 51/49 Combined‡
DVT & PE studies
SimpliRED D-dimer
Farrell et al, 2000
w6 173 55 41 ? ? 33 NA NA 100/0 Other**
Triage D-dimer
Ghys et al, 2007
w23 308 65 55 ? ? 3 NA NA 45/55 Combined‡
CUS, compression ultrasonography; DVT, deep venous thrombosis; NA, not applicable; PE, pulmonary embolism; ?, not reported
*Proportion distal and recurrent DVT among all DVT patients; †Proportion of patients who underwent an imaging test as the reference test/proportion of patients who had clinical follow-up
only as the reference test; ‡Both imaging and clinical follow-up as the reference test, where patients with a low pre-test probability and a negative D-dimer were not referred for imaging but
only followed up; §Only age range was given; ¶Patients initially underwent pulmonary imaging (ventilation-perfusion lung scan or computed tomography). In patients with a non-diagnostic
ventilation-perfusion lung scan, serial CUS, pulmonary angiography , or venography was used; **All patients underwent objective imaging. Those suspected of DVT also underwent CUS,
whereas those suspected of PE underwent a ventilation-perfusion lung scan, pulmonary angiography, or computed tomography scanning
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the pooled estimates to illustrate the precision with
which the pooled values were estimated (confidence
ellipse of a mean) and to show the amount of between
study variation (prediction ellipse; the likely range of
values for a new study).
Finally, we estimated the predictive value of the
pointofcareD-dimertests.GiventhatD-dimertesting
is predominately used to exclude venous thrombo-
embolism, the post-test probability of a negative
D-dimer test—that is, the negative predictive value—
is of highest importance. As the incidence of venous
thromboembolism followingnormal resultsfrom ima-
gingtestsisaround2%forpatientssuspectedofDVT,
6
a post-test probability of 2% or less would be accepted
as safe. According to Bayes’ theorem, the post-test
probability of a negative test can be calculated using
the negative likelihood ratio; that is, the pre-test odds
multiplied by the likelihood ratio of a negative test
result(LR-), wherepre-testoddsiscalculatedby divid-
ing pre-test probability by (1-pre-test probability) and
the post-test probability comprises post-test odds
divided by (1+post-test odds).
18 The pooled estimates
of sensitivity and specificity were used to calculate the
averageLR-bydividing(1-sensitivity)overspecificity.
Subsequently, we estimated the negative predictive
value of the different point of care D-dimer tests for
three different clinically relevant prevalences of
venous thromboembolism:
619 5% prevalence (low
riskpatients);20%prevalence(moderateriskpatients);
and50%prevalence(highriskpatients).Whereappro-
priate, 95% confidence intervals were calculated.
We used STATA version 10.0 (StataCorp, College
Station, TX, USA), in particular the midas and metandi
commands, for all statistical analyses.
2021
RESULTS
Identification of studies and study quality
Oursearchyielded2022citations(fig1),203ofwhich
were retrieved for full text review. Of these, 180 arti-
cles were excluded, mainly because the particular
D-dimer test examined was not a point of care assay.
A total of 23 citations were included in the final ana-
lysis. The 23 studies included a large management
study (1002 patients suspected of DVT) that has
recently been accepted for publication and a recently
conducted study on the accuracy of different point of
careD-dimertests.
w1 w2Thefinalanalysisincluded 12
studies evaluating SimpliRED D-dimer,
w3-w14 seven
looking at Clearview Simplify D-dimer,
w1 w2 w15-w19
four examining Cardiac D-dimer,
w2 w20-w22 and two
assessing Triage D-dimer.
w2 w23
In total, we included 6796 patients tested with
SimpliRED D-dimer, 5730 patients tested with
Clearview Simplify D-dimer, 925 patients tested with
Cardiac D-dimer, and 508 patients tested with Triage
D-dimer, of which 1272/6796 (18.7%), 470/5730
(8.2%), 317/925 (33.9%), and 67/508 (13.2%) were
diagnosed with venous thromboembolism, respec-
tively. Mean age of included patients varied across
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Fig 3 | Receiver operating characteristic graphs with 95%
confidence region and 95% prediction region for SimpliRED,
Clearview Simplify, and Cardiac D-dimer.
Abbreviation: HSROC, hierarchical summary receiver
operating characteristic
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ranged from 30% to 55%.
Overall,thequalityoftheincludedstudieswasgood
(fig 2). All studies used a prospective study design and
enrolled consecutive outpatients suspected of venous
thromboembolism. Among the possible sources of
biasindiagnosticaccuracystudies,differentialverifica-
tion and incorporation bias were present most often at
30%and31%,respectively.Also,blindingofindexand
reference test results was poorly reported, as was the
presence of uninterpretable test results.
Study and population characteristics
Of the 12 SimpliRED D-dimer studies, eight evaluated
patients suspected of DVT, three studied patients sus-
pected of PE, and one studied both types of patient
(table 1). Of the seven Clearview Simplify D-dimer
studies, four assessed patients suspected of DVT and
three evaluated patients suspected of PE, whereas one
of the two Triage D-dimer studies included patients
suspected of DVT or PE and the other only patients sus-
pected of DVT. All four Cardiac D-dimer studies
focused on DVT only. Table 1 lists the other study and
population characteristics of all 25 patient populations.
Diagnostic accuracy indices of point of care D-dimer tests
Overall analysis
The pooled sensitivity and specificity of all studies
combined was 0.88 (95% confidence interval 0.83 to
0.92) and 0.70 (0.62 to 0.77), respectively. As anti-
cipated, the between study variability beyond what
could be expected by sampling error was substantial,
with an I
2 of 80% for the sensitivity resultsand 96% for
the specificity results. Analysis of small study effects,
potentially a result of publication bias, yielded no sig-
nificant evidence for such effects (P=0.23).
Per test analyses
The pooled sensitivity (based on the bivariate model) of
SimpliRED, Clearview Simplify, and Cardiac D-dimer
was 0.85 (95% confidence interval 0.78 to 0.90), 0.87
(0.81 to 0.91), and 0.96 (0.91 to 0.98), respectively
(fig 3, table 2); the overall specificity was 0.74 (0.69 to
0.78), 0.62 (0.54to 0.69), and 0.57 (0.52 to 0.62), respec-
tively.AsonlytwostudiesevaluatedTriageD-dimer,an
overallsensitivityandspecificitycouldnotbecalculated
usingthebivariateapproach.Thetraditionalsamplesize
weightedapproachyieldedanaveragesensitivityof0.93
(0.88 to 0.97) and specificity of 0.48 (0.33 to 0.62).
16
Covariate analysis
Results from the covariate analysis are presented in
table 2. Both the sensitivity and specificity of Sim-
pliRED D-dimer and Clearview Simplify D-dimer
did not vary across covariates and were essentially
the same as in the overall analysis (table 2).
Negative predictive value
Table 3showstowhatextentthedifferentpointofcare
D-dimer assays changed the post-test probability of
venous thromboembolism—that is, the incidence of
venous thromboembolism following normal results
from a point of care D-dimer test —for different clini-
callyrelevantpre-testprobabilities.Forexample,ifthe
prevalence of venous thromboembolism is high (50%)
in a suspected population, a negative Clearview Sim-
plify D-dimertest yieldsa post-testprobability of 18%.
If, however, venous thromboembolism prevalence in
the population is low (5%), a negative Clearview Sim-
plifyD-dimertestreducesthisprevalencetoapost-test
probability of 1.1%. Figure 4 can be used to estimate
post-test probabilities for other pre-test probabilities.
DISCUSSION
This is the first meta-analysis of studies on the currently
availablepointofcareD-dimertests.MeasuringD-dimer
levels is an important step in the diagnostic investigation
of patients suspected of venous thromboembolism. A
negative D-dimer test result in combination with a low
pre-test probability of venous thromboembolism is
widely used to exclude the diagnosis and thus safely
reduce the number of unnecessary referrals for
imaging.
10 A meta-analysis performed by Fancher et al
in 2004 concluded that a negative result on SimpliRED
D-dimer could exclude venous thromboembolism in
low risk patients
9; however, after 2004 various newer
point of care D-dimer tests (qualitative as well as quanti-
tative)havebecomeavailable.Wesummarisedthelitera-
ture on the diagnostic accuracy of these point of care
assays, including the older SimpliRED D-dimer.
Table 2 |Overall and covariate analysis for point of care D-dimer tests
Number of
studies Sensitivity (95% CI) Specificity (95% CI)
SimpliRED D-dimer
Overall analysis* 12 0.85 (0.78 to 0.90) 0.74 (0.69 to 0.78)
Covariate analysis†
Only DVT (proximal and
distal)
8 0.86 (0.78 to 0.91) 0.75 (0.68 to 0.80)
No differential verification
bias
8 0.84 (0.75 to 0.90) 0.75 (0.69 to 0.80)
No incorporation bias 8 0.84 (0.75 to 0.90) 0.75 (0.69 to 0.80)
Clearview Simplify D-dimer
Overall analysis* 7 0.87 (0.81 to 0.91) 0.62 (0.54 to 0.69)
Covariate analysis†
Only DVT (proximal and
distal)
4 0.88 (0.82 to 0.93) 0.56 (0.48 to 0.64)
No differential verification
bias
4 0.87 (0.79 to 0.93) 0.60 (0.47 to 0.71)
No incorporation bias 4 0.87 (0.79 to 0.93) 0.60 (0.47 to 0.71)
Cardiac D-dimer
Overall analysis* 4 0.96 (0.91 to 0.98) 0.57 (0.52 to 0.62)
Triage D-dimer‡ ‡
Overall analysis 2 0.93 (0.88 to 0.97) 0.48 (0.33 to 0.62)
*Between study variance for logit sensitivity and logit specificity were: 0.51 and 0.14 for SimpliRED D-dimer;
0.14 and 0.18 for Clearview Simplify D-dimer; and 0.15 and 0.01 for Cardiac D-dimer. Between study correlation
for SimpliRED D-dimer, Clearview Simplify D-dimer, and Cardiac D-dimer was −0.76, −1, and 1, respectively.
†Owing to missing information on the other a priori defined covariates (see methods) in several studies and the
limited number of studies available, covariate analysis was only possible for the following characteristics: type
of venous thromboembolism; differential verification bias; and incorporation bias.
‡For Triage D-dimer, pooled sensitivity and specificity could not be calculated using the bivariate model owing
to the small number of studies available. Instead, the traditional sample size weighted approach was used.
16
Abbreviations: DVT, deep vein thrombosis.
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(SimpliRED D-dimer and Clearview Simplify D-dimer)
have a lower sensitivity (that is, a higher number of false
negatives) but higher specificity (that is, a lower number
of false positives) than the quantitative assays (Cardiac
D-dimer and Triage D-dimer). The latter seem, there-
fore, better suited to rule out DVT in suspected patients:
theydecreasethepre-testprobabilityofvenousthrombo-
embolism more effectively. In this regard, Cardiac
D-dimer outperforms Triage D-dimer, as it is able to
rule out DVT both in patients with a low pre-test risk
and in those with a moderate pre-test risk.
Strengths and limitations
Some methodological issues need to be considered.
Firstly, we found substantial heterogeneity across the
SimpliRED D-dimer studies. This variation could not
be corrected for or explained by adding covariates in
the bivariate meta-regression model. In the summary
receiver operating characteristic graph, all but three of
the 12 ‘sensitivity - (1-specificity)’ combinations of the
individual SimpliRED D-dimer studies lie on or near
the receiver operating characteristic curve; therefore,
studieswithahighersensitivityhavealowerspecificity
and vice versa. This pattern is commonly attributed to
differences in the threshold for test positivity used in
thedifferentstudies.
16Indeed,theheterogeneityacross
the SimpliRED studies could well be explained by
threshold differences, as defining a positive test result
for this point of care D-dimer test is subjective and
depends on the amount of visible agglutination seen.
This assessment may have low interobserver agree-
ment and, therefore, different thresholds for test
positivity.
1112 Threshold differences across diagnostic
studies are implicit, so they cannot be accounted for in
the analysis. Hence, calculating a common underlying
sensitivity and specificity of SimpliRED D-dimer
might not be possible with the currently available
data. The use of quantitative point of care assays and
further standardising the interpretation of qualitative
point of care tests will surely reduce this problem.
Secondly,mostof the studiesin ourreview included
patients suspected of DVT. Only six studies evaluated
patients suspected of PE. In patients with PE, there is a
strong correlation between embolus location and D-
dimer levels. Small sub-segmental thrombi result in
less D-dimer formation, so D-dimer tests have lower
sensitivity in patients suspected of PE.
22 Indeed, the
two of the three Clearview Simplify D-dimer studies
thatincludedpatientssuspectedofPE hadlowersensi-
tivity than the studies that only included patients sus-
pected of DVT.
w15 w16 No studies on the diagnostic
accuracyoftheCardiacD-dimerforpatientssuspected
of PE were available; therefore, our results for patients
suspected of PE should be interpreted with more cau-
tion than those relating to patients with DVT.
Thirdly, different studies used different reference
standards to diagnose or exclude venous thrombo-
embolism. As with many reference standards, none
was a 24 carat gold standard. For example, compres-
sion ultrasonography is used as the reference standard
in most DVT studies. A meta-analysis by Goodacre et
alfoundapooledsensitivityofcompressionultrasono-
graphy for detection of proximal DVT of 0.94, com-
pared with venography as reference standard.
23 This
finding implies that even compression ultrasono-
graphy might miss a small proportion of DVT cases.
Given that most of the DVT studies in our analysis
used compression ultrasonography as the reference
standard, the reported pooled sensitivity of the point
of care D-dimer tests could thus be slightly overesti-
mated. Compression ultrasonography is now the
accepted reference standard in daily clinical practice,
however, and the use of a reference standard with a
higher sensitivity—such as venography—is no longer
advocated in guidelines. Also, many studies use
uneventful follow-up to exclude venous thrombo-
embolism, a common approach in this field of
research. The inclusion in our analysis of studies that
used uneventful follow-up could lead to a small over-
estimation of the sensitivity of point of care D-dimer
tests, as patients with negative test results but mild
DVTand/orPEcouldbemissediftheyweremanaged
with uneventful follow-up only.
Fourthly, we restricted our search to studies pub-
lishedinEnglishonly,whichcouldhavebeenapoten-
tial source of bias. We complemented our electronic
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Fig 4 | Fagan’s nomogram for Cardiac D-dimer (dashed red line)
and Clearview Simplify D-dimer (solid blue line), with a fixed
post-test probability of 2%. If post-test probability is fixed at
the accepted safety standard of 2%, Cardiac D-dimer can
exclude venous thromboembolism in patients with a pre-test
probability of up to 27%, compared with 9% with Clearview
Simplify D-dimer. For other pre-test probabilities, the post-
test probability can be calculated by simply drawing a line
through the negative likelihood ratio of the respective point of
care D-dimer test and the chosen pre-test probability
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the field, however, and this approach retrieved no
non-Englishstudies.Inaddition,non-Englishstudies
often have little effect on summary estimates in
meta-analyses.
24
Fifthly, although the quality of included studies was
good in general, several studies had differential verifi-
cation bias and/or incorporation bias (30% and 31%,
respectively). The former refers to bias introduced by
theuseofdifferentreferencestandardsforpositiveand
negative test results. For example, patients with a
positive point of care D-dimer test result undergo
invasive imaging as reference standard, whereas
patients with negative point of care D-dimer tests
only receive follow-up or less invasive imaging tests
as reference standard. Incorporation bias occurs
when the index test is also part of the reference stan-
dard. For example, venous thromboembolism is
excluded in patients with a low probability ventila-
tion-perfusion scan only if the point of care D-dimer
(indextest)isnegative.Lijmeretalhavedemonstrated
that both forms of bias can affect (often overestimate)
the diagnostic performance of an index test.
25 How-
ever,addingbothformsofbiasintoacovariateanalysis
did not change the overall sensitivity and specificity
of SimpliRED D-dimer and Clearview Simplify
D-dimer. A covariate analysis was not possible for
Cardiac D-dimer and Triage D-dimer owing to the
limited amount of studies available on these tests;
however, studies on these tests (notably those on
CardiacD-dimer)didnothavedifferentialverification
and/or incorporation bias.
Finally, only two studies were performed on Triage
D-dimer and only four were performed on Cardiac
D-dimer, thus limiting the precision of our results for
these tests.
Implications
The laboratory based enzyme linked immunosorbent
assay (ELISA) is currently advocated in the literature
asthebestD-dimertestforexcludingvenousthrombo-
embolism in a hospital setting. Stein and colleagues
report in their meta-analysis that ELISA for D-dimer
has an overall sensitivity of 0.96 for DVT and 0.95 for
PE.
8 We found in our meta-analysis that the quantita-
tive point of care D-dimer tests (Cardiac D-dimer and
Triage D-dimer) indeed have similar sensitivity to
ELISA for D-dimer. According to Stein and collea-
gues, the overall sensitivity of laboratory based latex
D-dimer tests is 0.85 and 0.89 for DVT and PE,
respectively,
8 which is equal to the average accuracy
of the Clearview Simplify point of care D-dimer test.
Physicians,especiallythoseinprimarycare,arecon-
fronted with a wide spectrum of patients suspected of
venousthromboembolism.Thisspectrumcouldrange
from a low risk patient—for example, a 32 year old
female on oral contraceptives with minor swelling of
the leg—to a high risk patient—such as a 78 year old
male with a disseminated malignancy, acute onset of
dyspnoea with pain on inspiration, and swelling of
the entire leg. However, patients in daily practice are
hardly ever “textbook patients.” It is not uncommon
for the low risk patient to have DVT and the high risk
patient to be diagnosed with another disease, such as
heartfailure.Hence,itisdifficulttomakeadecisionon
which patients are to be referred for reference testing
(imaging) on the basis of signs and symptoms only.
Moreover, this decision often has to be made at the
point of care; that is, during the consultation of the
patient.Onepossibilityisreferringallpatientsforima-
ging, but this approach has a poor yield of confirmed
cases of venous thromboembolism (the prevalence of
venous thromboembolism has even decreased below
10% in recent years
26) and thus seems not very cost
effective. Physicians in daily practice are, therefore, in
needofsimpleandsafeadditionaltests,suchaspointof
care D-dimer tests, to guide them in their diagnostic
decision making.
According to our analysis, using a diagnostic strategy
that includes point of care D-dimer testing to rule out
venousthromboembolismwithouttheneedforimaging
could achieve a post-test probability of 2% or less. This
probability threshold is generally accepted as safe
because the incidence of venous thromboembolism
following normal imaging tests, such as compression
ultrasonography in patients suspected of DVT, is also
around 1-2%.
6 Applying this “safety threshold” to our
results indicates that all point of care D-dimer tests are
sufficiently safe in low risk patients, as they achieved a
post-test probability of 0.4-1.1% (table 3 and fig 4).
Cardiac D-dimer seems to be the only test with the
capacity to exclude DVT in patients with a moderate
pre-test probability (up to 27%; fig 4), although only
Table 3 |Analysis of the negative predictive value of point of care D-dimer tests for patients
at low, moderate, and high risk of VTE
Likelihood ratio of a negative test
result (95% CI)
Post-test probability of a negative
test result (95% CI)
SimpliRED D-dimer 0.21 (0.15 to 0.29)*
Low risk 1.1% (0.8 to 1.5)
Moderate risk 4.9% (3.6 to 6.8)
High risk 17.4% (13.0 to 22.5)
Clearview Simplify D-dimer 0.22 (0.17 to 0.28)*
Low risk 1.1% (0.9 to 1.5)
Moderate risk 5.2% (4.1 to 6.5)
High risk 18.0% (14.5 to 21.9)
Cardiac D-dimer 0.07 (0.04 to 0.16)*
Low risk 0.4% (0.2 to 0.8)
Moderate risk 1.7% (1.0 to 3.8)
High risk 6.5% (3.8 to 13.7)
Triage D-dimer 0.18 (0.08 to 0.43)†
Low risk 0.9% (0.4 to 2.2)
Moderate risk 4.3% (2.0 to 9.7)
High risk 15.3% (7.4 to 30.1)
VTE, venous thromboembolism.
Low risk=5%, moderate risk=20%; and high risk=50%.
*The likelihood ratio of a negative test result is calculated by dividing (1-sensitivity) over specificity, using the
pooled estimates from the bivariate model.
†For Triage D-dimer, the likelihood ratio of a negative test result is calculated using the sample size weighted
sensitivity and specificity.
RESEARCH
page 8 of 9 BMJ | ONLINE FIRST | bmj.comfourstudiesonCardiacD-dimerwereavailableandthus
the 95% confidence interval exceeds 2%.
The decision on which point of care D-dimer test to
use depends on the setting. In primary care, the Clear-
view Simplify D-dimer test has the advantage that it
can be performed with capillary blood and thus does
not require any other equipment. This makes it possi-
bletohaveatestresultevenwhenmakingahousecall,
although at the expense of a lower sensitivity than the
quantitative tests. This user friendliness is less impor-
tant in an emergency department setting, where Car-
diac D-dimer and Triage D-dimer may be preferable.
These two tests might be a better option not only
because of their superior accuracy, but also because
other cardiovascular biomarkers—such as brain
natriuretic peptide, troponin, and C reactive protein
—can be measured with the same instrument.
Conclusions
BothqualitativeandquantitativepointofcareD-dimer
tests can safely exclude venous thromboembolism in
low risk outpatients. Quantitative tests seem to per-
formbetterthanqualitativetests,althoughthequantity
ofavailabledataisstilllimited.Also,thereareonlyfew
studiesofthesetestsinpatientssuspectedofPE.Inout-
patients suspected of DVT, however, point of care
D-dimer tests can contribute important information
and guide patient management.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Several meta-analyses have shown that laboratory based
D-dimer testing—such as enzyme linked immunosorbent
assay—can be used to exclude venous thromboembolism
Excluding venous thromboembolism commonly requires
referring a patient to a central laboratory facility
Point of care D-dimer tests are available that could enable
exclusion of venous thromboembolism in a near patient
situation; however, their diagnostic accuracy is largely
unknown
WHAT THIS PAPER ADDS
Point of care D-dimer tests can safely exclude venous
thromboembolism in low risk outpatients
Such tests can, therefore, contribute important information
at the point of care and guide patient management
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